Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Rhodamine-Hoechst positional isomers for highly efficient staining of heterochromatin.

Bucevičius J, Keller-Findeisen J, Gilat T, Hell SW, Lukinavičius G.

Chem Sci. 2018 Dec 12;10(7):1962-1970. doi: 10.1039/c8sc05082a. eCollection 2019 Feb 21.

2.

Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trial.

Oren R, Moshkowitz M, Odes S, Becker S, Keter D, Pomeranz I, Shirin C, Reisfeld I, Broide E, Lavy A, Fich A, Eliakim R, Patz J, Villa Y, Arber N, Gilat T.

Am J Gastroenterol. 2015 Apr;110(4):608. doi: 10.1038/ajg.2015.61. No abstract available.

PMID:
25853210
3.

The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease.

Safadi R, Konikoff FM, Mahamid M, Zelber-Sagi S, Halpern M, Gilat T, Oren R; FLORA Group.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):2085-91.e1. doi: 10.1016/j.cgh.2014.04.038. Epub 2014 May 9.

4.

Fatty acid bile acid conjugate inhibits hepatic stearoyl coenzyme A desaturase and is non-atherogenic.

Leikin-Frenkel A, Gonen A, Shaish A, Goldiner I, Leikin-Gobbi D, Konikoff FM, Harats D, Gilat T.

Arch Med Res. 2010 Aug;41(6):397-404. doi: 10.1016/j.arcmed.2010.09.001.

PMID:
21044742
5.

Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents.

Leikin-Frenkel A, Goldiner I, Leikin-Gobbi D, Rosenberg R, Bonen H, Litvak A, Bernheim J, Konikoff FM, Gilat T.

Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1205-13. doi: 10.1097/MEG.0b013e3282fc9743.

PMID:
18989145
6.

Hypocholesterolemic effects of fatty acid bile acid conjugates (FABACs) in mice.

Leikin-Frenkel A, Parini P, Konikoff FM, Benthin L, Leikin-Gobbi D, Goldiner I, Einarsson C, Gilat T.

Arch Biochem Biophys. 2008 Mar 1;471(1):63-71. doi: 10.1016/j.abb.2007.12.005. Epub 2007 Dec 23.

PMID:
18167305
7.

ABCA1-dependent but apoA-I-independent cholesterol efflux mediated by fatty acid-bile acid conjugates (FABACs).

Goldiner I, van der Velde AE, Vandenberghe KE, van Wijland MA, Halpern Z, Gilat T, Konikoff FM, Veldman RJ, Groen AK.

Biochem J. 2006 Jun 15;396(3):529-36.

8.

Effects of fatty acid bile acid conjugates (FABACs) on biliary lithogenesis: potential consequences for non-surgical treatment of gallstones.

Konikoff FM, Gilat T.

Curr Drug Targets Immune Endocr Metabol Disord. 2005 Jun;5(2):171-5. Review.

PMID:
16089349
9.

Faecal sterol output is increased by arachidyl amido cholanoic acid (Aramchol) in rats.

Leikin-Frenkel A, Weinbroum AA, Leikin-Gobbi D, Krupitzky L, Goldiner I, Shafat L, Gilat T, Konikoff FM.

Biochem Soc Trans. 2004 Feb;32(Pt 1):131-3.

PMID:
14748731
10.

Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC).

Gilat T, Leikin-Frenkel A, Goldiner I, Juhel C, Lafont H, Gobbi D, Konikoff FM.

Hepatology. 2003 Aug;38(2):436-42.

PMID:
12883488
11.

Biliary and systemic effects of fatty acid bile acid conjugates.

Konikoff FM, Leikin-Frenkel A, Goldiner I, Michowitz M, Brezowski E, Harats D, Gilat T.

Eur J Gastroenterol Hepatol. 2003 Jun;15(6):649-55.

PMID:
12840677
12.

Fatty acid bile acid conjugates inhibit atherosclerosis in the C57BL/6 mouse model.

Gonen A, Shaish A, Leikin-Frenkel A, Gilat T, Harats D.

Pathobiology. 2002-2003;70(4):215-8.

PMID:
12679599
13.

Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate.

Gilat T, Leikin-Frenkel A, Goldiner I, Halpern Z, Konikoff FM.

Hepatology. 2002 Mar;35(3):597-600.

PMID:
11870372
14.

Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice.

Gilat T, Leikin-Frenkel A, Goldiner L, Laufer H, Halpern Z, Konikoff FM.

Lipids. 2001 Oct;36(10):1135-40.

PMID:
11768158
15.

Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study.

Lavy A, Broide E, Reif S, Keter D, Niv Y, Odes S, Eliakim R, Halak A, Ron Y, Patz J, Fich A, Villa Y, Arber N, Gilat T.

Dig Liver Dis. 2001 Aug-Sep;33(6):472-6.

PMID:
11572573
16.

Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis.

Odes HS, Fich A, Reif S, Halak A, Lavy A, Keter D, Eliakim R, Paz J, Broide E, Niv Y, Ron Y, Villa Y, Arber N, Gilat T.

Dig Dis Sci. 2001 Aug;46(8):1717-21.

PMID:
11508673
17.

Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease.

Reif S, Lavy A, Keter D, Broide E, Niv Y, Halak A, Ron Y, Eliakim R, Odes S, Patz J, Fich A, Villa Y, Arber N, Gilat T.

Am J Gastroenterol. 2001 Mar;96(3):829-32.

PMID:
11280559
18.

Determination of bile acids in biological fluids by liquid chromatography-electrospray tandem mass spectrometry.

Perwaiz S, Tuchweber B, Mignault D, Gilat T, Yousef IM.

J Lipid Res. 2001 Jan;42(1):114-9.

19.

Fatty acid bile acid conjugates (FABACs)--new molecules for the prevention of cholesterol crystallisation in bile.

Gilat T, Somjen GJ, Mazur Y, Leikin-Frenkel A, Rosenberg R, Halpern Z, Konikoff F.

Gut. 2001 Jan;48(1):75-9.

20.

Pregnancy and the biliary tract.

Gilat T, Konikoff F.

Can J Gastroenterol. 2000 Nov;14 Suppl D:55D-59D. Review.

PMID:
11110613
21.

Passive smoking in patients with inflammatory bowel disease: an Israeli multicentre case-control study.

Eliakim R, Reif S, Lavy A, Keter D, Odes S, Halak A, Broide E, Niv Y, Ron Y, Paz J, Fich A, Villa Y, Gilat T.

Eur J Gastroenterol Hepatol. 2000 Sep;12(9):975-9.

PMID:
11007132
22.

Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, Gilat T, Weiss J, Walach E, Amazeen P, Irving CS.

Invest Radiol. 2000 May;35(5):319-24.

PMID:
10803673
23.

Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study.

Reif S, Lavy A, Keter D, Fich A, Eliakim R, Halak A, Broide E, Niv Y, Ron Y, Patz J, Odes S, Villa Y, Gilat T.

Am J Gastroenterol. 2000 Feb;95(2):474-8.

PMID:
10685753
24.

The effects of short term lipid infusion on plasma and hepatic bile lipids in humans.

Pakula R, Konikoff FM, Moser AM, Greif F, Tietz A, Gilat T, Rubin M.

Gut. 1999 Sep;45(3):453-8.

25.
26.

Decreased fecal bile acid output in patients with coronary atherosclerosis.

Charach G, Rabinovich PD, Konikoff FM, Grosskopf I, Weintraub MS, Gilat T.

J Med. 1998;29(3-4):125-36.

PMID:
9865454
27.

Preillness non dietary factors and habits in inflammatory bowel disease.

Klein I, Reif S, Farbstein H, Halak A, Gilat T.

Ital J Gastroenterol Hepatol. 1998 Jun;30(3):247-51.

PMID:
9759588
28.

The effects of phospholipid molecular species on cholesterol crystallization in model biles: the influence of phospholipid head groups.

Ringel Y, Sömjen GJ, Konikoff FM, Rosenberg R, Michowitz M, Gilat T.

J Hepatol. 1998 Jun;28(6):1008-14.

PMID:
9672177
29.

Increased saturation of the fatty acids in the sn-2 position of phospholipids reduces cholesterol crystallization in model biles.

Ringel Y, Sömjen GJ, Konikoff FM, Rosenberg R, Gilat T.

Biochim Biophys Acta. 1998 Feb 23;1390(3):293-300.

PMID:
9487150
30.

Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.

Oren R, Moshkowitz M, Odes S, Becker S, Keter D, Pomeranz I, Shirin H, Reisfeld I, Broide E, Lavy A, Fich A, Eliakim R, Patz J, Villa Y, Arber N, Gilat T.

Am J Gastroenterol. 1997 Dec;92(12):2203-9. Erratum in: Am J Gastroenterol. 2015 Apr;110(4):608. Shirin, C [corrected to Shirin, H].

PMID:
9399753
31.

Calcium and the anionic polypeptide fraction (APF) have opposing effects on cholesterol crystallization in model bile.

Konikoff FM, Lechene de la Porte P, Laufer H, Domingo N, Lafont H, Gilat T.

J Hepatol. 1997 Oct;27(4):707-15.

PMID:
9365047
32.

Imaging supramolecular aggregates in bile models and human bile.

Kaplun A, Konikoff FM, Eitan A, Rubin M, Vilan A, Lichtenberg D, Gilat T, Talmon Y.

Microsc Res Tech. 1997 Oct 1;39(1):85-96.

PMID:
9329021
33.

Ulcerative colitis and appendectomy. What is the nature of the (negative) association?

Gilat T, Dotan I.

Ital J Gastroenterol Hepatol. 1997 Jun;29(3):212-3. No abstract available.

PMID:
9646211
34.

Pre-illness dietary factors in inflammatory bowel disease.

Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T.

Gut. 1997 Jun;40(6):754-60.

35.

The absorption of low-dose methotrexate in patients with inflammatory bowel disease.

Moshkowitz M, Oren R, Tishler M, Konikoff FM, Graff E, Brill S, Yaron M, Gilat T.

Aliment Pharmacol Ther. 1997 Jun;11(3):569-73.

36.

A new method for the rapid measurement of cholesterol crystallization in model biles using a spectrophotometric microplate reader.

Sömjen GJ, Ringel Y, Konikoff FM, Rosenberg R, Gilat T.

J Lipid Res. 1997 May;38(5):1048-52.

37.

Primary liver gastrinoma.

Tiomny E, Brill S, Baratz M, Messer G, Greif F, Moshkowitz M, Gilat T.

J Clin Gastroenterol. 1997 Apr;24(3):188-91. No abstract available.

PMID:
9179744
38.

Monitoring cholesterol crystallization from lithogenic model bile by time-lapse density gradient ultracentrifugation.

Konikoff FM, Laufer H, Messer G, Gilat T.

J Hepatol. 1997 Mar;26(3):703-10.

PMID:
9075680
39.

One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.

Moshkowitz M, Konikoff FM, Peled Y, Brill S, Hallak A, Tiomny E, Santo M, Bujanover Y, Gilat T.

Aliment Pharmacol Ther. 1996 Dec;10(6):1015-9.

PMID:
8971304
40.

Characteristics of gallbladder bile of infants and children.

Halpern Z, Vinograd Z, Laufer H, Gilat T, Moskowitz M, Bujanover Y.

J Pediatr Gastroenterol Nutr. 1996 Aug;23(2):147-50.

PMID:
8856581
41.

Esophageal smooth muscle dysfunction in oculopharyngeal muscular dystrophy.

Tiomny E, Khilkevic O, Korczyn AD, Kimmel R, Hallak A, Baron J, Blumen S, Asherov A, Gilat T.

Dig Dis Sci. 1996 Jul;41(7):1350-4.

PMID:
8689911
42.

Phospholipid vesicles and other cholesterol carriers in bile.

Gilat T, Sömjen GJ.

Biochim Biophys Acta. 1996 Jun 10;1286(2):95-115. Review. No abstract available.

PMID:
8652613
43.

Increased leukocyte adhesiveness/aggregation in patients with inflammatory bowel disease during remission. Further evidence for subclinical inflammation.

Arber N, Hallak A, Dotan I, Bujanover Y, Liberman E, Santo M, Moshkowitz M, Tiomny E, Aronson M, Berliner S, Gilat T.

Dis Colon Rectum. 1996 Jun;39(6):632-5.

PMID:
8646948
44.

Lithogenicity of human bile is reduced by freezing and thawing.

Konikoff FM, Laufer H, Gilat T.

Clin Chim Acta. 1996 May 30;249(1-2):59-66.

PMID:
8737592
45.

Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial.

Oren R, Arber N, Odes S, Moshkowitz M, Keter D, Pomeranz I, Ron Y, Reisfeld I, Broide E, Lavy A, Fich A, Eliakim R, Patz J, Bardan E, Villa Y, Gilat T.

Gastroenterology. 1996 May;110(5):1416-21.

PMID:
8613046
46.

The effects of dietary phospholipids enriched with phosphatidylethanolamine on bile and red cell membrane lipids in humans.

Pakula R, Konikoff FM, Rubin M, Ringel Y, Peled Y, Tietz A, Gilat T.

Lipids. 1996 Mar;31(3):295-303.

PMID:
8900459
47.

Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD.

Campieri M, Gilat T, Hanauer S, Korelitz B, Lauritsen K, Malchow H, Martin F, Miglioli M, Modigliani R, Present D, Schölmerich J, Sutherland L.

Inflamm Bowel Dis. 1996 Winter;2(4):265-7. No abstract available.

PMID:
23282593
48.

Increased leukocyte adhesiveness/aggregation is the single best biochemical indicator of disease activity in adolescent patients with inflammatory bowel disease.

Arber N, Berliner S, Reif S, Dotan I, Liberman E, Aschkenasy M, Vila Y, Gilat T, Bujanover Y.

J Med. 1996;27(5-6):319-31.

PMID:
9151200
49.

Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection.

Arber N, Moshkowitz M, Konikoff F, Halpern Z, Hallak A, Santo M, Tiomny E, Baratz M, Gilat T.

Dig Dis Sci. 1995 Nov;40(11):2431-3.

PMID:
7587826
50.

Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel.

Reif S, Klein I, Arber N, Gilat T.

Gastroenterology. 1995 Jun;108(6):1683-7.

PMID:
7768372

Supplemental Content

Support Center